Scholar Rock, LLC, a biotechnology company focused on discovering and developing novel therapeutics for targeting the disease microenvironment, announced today that Katrine Bosley and Michael Gilman, Ph.D., have joined the company’s Board of Directors. Each of these new board members brings more than 25 years of strategic, operational and management experience in the biotechnology industry, particularly in building biotechnology companies with novel science and managing these companies to create significant value.
Help employers find you! Check out all the jobs and post your resume.
